METAPROTERENOL SULFATE - Generic Drug Details

« Back to Dashboard

What are the generic sources for metaproterenol sulfate and what is the scope of patent protection?

Metaproterenol sulfate is the generic ingredient in three branded drugs marketed by Boehringer Ingelheim, Apotex Inc, Astrazeneca, DEY, Mylan Speciality Lp, Nephron, Wockhardt, Muro, Chartwell, Cosette Pharms Nc, G And W Labs Inc, Morton Grove, Am Therap, Heritage Pharma, Strides Pharma Intl, Usl Pharma, and Watson Labs, and is included in thirty-six NDAs. Additional information is available in the individual branded drug profile pages.

Summary for METAPROTERENOL SULFATE

US Patents:	0
Tradenames:	3
Applicants:	17
NDAs:	36
Raw Ingredient (Bulk) Api Vendors:	1
Patent Applications:	4,269
What excipients (inactive ingredients) are in METAPROTERENOL SULFATE?	METAPROTERENOL SULFATE excipients list
DailyMed Link:	METAPROTERENOL SULFATE at DailyMed

Medical Subject Heading (MeSH) Categories for METAPROTERENOL SULFATE

Adrenergic beta-2 Receptor Agonists

Bronchodilator Agents

Sympathomimetics

Tocolytic Agents

US Patents and Regulatory Information for METAPROTERENOL SULFATE

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Muro	PROMETA	metaproterenol sulfate	SYRUP;ORAL	072023-001	Sep 15, 1988		DISCN	No	No
Boehringer Ingelheim	ALUPENT	metaproterenol sulfate	SYRUP;ORAL	017571-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Astrazeneca	METAPROTERENOL SULFATE	metaproterenol sulfate	SOLUTION;INHALATION	071275-001	Jul 27, 1988		DISCN	No	No
Wockhardt	METAPROTERENOL SULFATE	metaproterenol sulfate	SOLUTION;INHALATION	075586-002	May 30, 2002		DISCN	No	No
Am Therap	METAPROTERENOL SULFATE	metaproterenol sulfate	TABLET;ORAL	072054-001	Jun 23, 1988		DISCN	No	No
Chartwell	METAPROTERENOL SULFATE	metaproterenol sulfate	SYRUP;ORAL	073632-001	Jul 22, 1992		RX	No	Yes
Boehringer Ingelheim	ALUPENT	metaproterenol sulfate	SOLUTION;INHALATION	018761-001	Jun 30, 1983		DISCN	No	No

Expired US Patents for METAPROTERENOL SULFATE

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Boehringer Ingelheim	ALUPENT	metaproterenol sulfate	SYRUP;ORAL	017571-001	Approved Prior to Jan 1, 1982	3,422,196
Boehringer Ingelheim	ALUPENT	metaproterenol sulfate	AEROSOL, METERED;INHALATION	016402-001	Approved Prior to Jan 1, 1982	3,422,196
Boehringer Ingelheim	ALUPENT	metaproterenol sulfate	TABLET;ORAL	015874-002	Approved Prior to Jan 1, 1982	3,422,196
Boehringer Ingelheim	ALUPENT	metaproterenol sulfate	SOLUTION;INHALATION	017659-001	Approved Prior to Jan 1, 1982	3,422,196
Boehringer Ingelheim	ALUPENT	metaproterenol sulfate	TABLET;ORAL	015874-001	Approved Prior to Jan 1, 1982	3,422,196
Boehringer Ingelheim	ALUPENT	metaproterenol sulfate	SOLUTION;INHALATION	018761-001	Jun 30, 1983	3,422,196